Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
BCAL Diagnostics Limited, a biotechnology company, engages in developing a non-invasive laboratory blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is 'cheap' on P/E.
Target Price
The average target price of BDX.AX is 0.20 and suggests 74% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell